-
<![CDATA[Isatuximab Subcutaneous (ISA SC) via On-Body Injector (OBI) or Manual Injection For Relapsed/Refractory Multiple Myeloma (RRMM): Patient Experience From the Phase 2 IZALCO Study]]>
22 Oct 2025 19:17 GMT
-
S2 Episode 4: Treating Smoldering Multiple Myeloma
22 Oct 2025 14:22 GMT
… standard multiple myeloma therapy for high-risk, smoldering multiple myeloma is … Slim CRAB Criteria Influence Multiple Myeloma Diagnostic Activity
International … Diagnosed Multiple Myeloma
CD38-Directed Therapies for Management of Multiple Myeloma
Fixed …
-
Blood Publishes Promising Results of IASO Bio’s Anti-GPRC5D CAR-T RD118 in Relapsed/Refractory Multiple Myeloma
22 Oct 2025 14:17 GMT
… Remissions in Relapsed/Refractory Multiple Myeloma’ has been published in … School of Medicine, commented: “Multiple myeloma remains an incurable malignant plasma … 2024. The treatment landscape for multiple myeloma requires continuous innovation, and …
-
<![CDATA[Stage 1 Multiple Myeloma Treatment Options and Side Effect Management]]>
21 Oct 2025 22:55 GMT
… : What Defines Stage 1 Multiple Myeloma?
Multiple myeloma is a cancer of plasma … antibodies to fight infection. In multiple myeloma, cancerous plasma cells multiply … Life with Multiple Myeloma: Tips for Patients and Caregivers
A multiple myeloma diagnosis …
-
<![CDATA[Key Takeaways From IMS Real-World Data on Managing Step-Up Dosing in Relapsed/Refractory Multiple Myeloma]]>
21 Oct 2025 15:54 GMT
… of administering bispecific antibodies for multiple myeloma in an outpatient setting are … has the potential to transform multiple myeloma care across all stages of … signal a promising advancement in multiple myeloma management, underscoring the importance of …
-
<![CDATA[Expert Perspectives on Operationalizing Outpatient/Hybrid Step-Up Dosing in Relapsed/Refractory Multiple Myeloma]]>
21 Oct 2025 15:54 GMT
Findings from this study strongly support the feasibility and safety of administering bispecific antibody treatment for myeloma in an outpatient setting. However, patient selection remains critical. Although most patients can be safely managed with …
-
<![CDATA[Bispecific Antibody Therapies for Relapsed or Refractory Multiple Myeloma]]>
21 Oct 2025 13:41 GMT
Bispecific Antibody Therapies for Relapsed/Refractory Myeloma
Bispecific antibodies are offered to nearly all relapsed/refractory patients, with temporary deferral only for patients with active severe infections requiring initial infection control …
-
Counteracting Complacency in Multiple Myeloma—We’re Not There Yet
20 Oct 2025 04:15 GMT
… hold in multiple myeloma, a blood cancer that the Multiple Myeloma Research Foundation … ” or “functional” cure for multiple myeloma reveal a troubling disconnect between … past decade, capable of rendering multiple myeloma undetectable. Yet these treatments …
-
Multiple Myeloma: How it’s Damaging Your Bones and What You Can Do
18 Oct 2025 18:00 GMT
… tells Everyday Health that multiple myeloma causes osteoclasts to continuously break … Despite the challenges posed by multiple myeloma, there are several effective … -being.
Living Well With Multiple Myeloma
Multiple myeloma profoundly affects bone health, …
-
Remembering the late Kerry man Kevin O’Shea on his birthday
23 Oct 2025 06:45 GMT
… than six year battle with multiple myeloma – a type of blood cancer …